Paper1753797
Antibacterial, antifungal, antiamoebic, antiinflammatory and antipyretic studies on propolis bee products.
Dobrowolski JW and 5 others. J Ethnopharmacol, 1991. Cited by 158 papers, by iCite.
Cite this record
ConductScience Library. Antibacterial, antifungal, antiamoebic, antiinflammatory and antipyretic studies on propolis bee products. Papers, record 1753797. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1753797
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antibacterial, antifungal, antiamoebic, antiinflammatory and antipyretic studies on propolis bee products.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Anti-Inflammatory Agents, Non-Steroidal | Major topic |
| Antifungal Agents | Major topic |
| Bees | Major topic |
| Propolis | Major topic |
| Animals | |
| Arthritis | |
| Female | |
| Male | |
| Mice | |
| Microbial Sensitivity Tests | |
| Rats | |
| Rats, Inbred Strains |
Source PubMed
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 158 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39925210 | Novel compounds of Taiwanese green propolis induce apoptosis of human glioblastoma cells by daylight photodynamic action. | Future Sci OA | 2025 | https://conductscience.org/library/papers/39925210 | PubMed |
| 39863575 | Propolis mouthwashes efficacy in managing gingivitis and periodontitis: a systematic review of the latest findings. | BDJ Open | 2025 | https://conductscience.org/library/papers/39863575 | PubMed |
| 38961137 | Antiviral action of aqueous extracts of propolis from Scaptotrigona aff. postica (Hymenoptera; Apidae) against Zica, Chikungunya, and Mayaro virus. | Sci Rep | 2024 | https://conductscience.org/library/papers/38961137 | PubMed |
| 38582863 | Comparative effectiveness of Propolis with chlorhexidine mouthwash on gingivitis - a randomized controlled clinical study. | BMC Complement Med Ther | 2024 | https://conductscience.org/library/papers/38582863 | PubMed |
| 38291462 | Synergistic effect of potential alpha-amylase inhibitors from Egyptian propolis with acarbose using in silico and in vitro combination analysis. | BMC Complement Med Ther | 2024 | https://conductscience.org/library/papers/38291462 | PubMed |
| 38005805 | Examination of Raw Samples and Ethanol Extracts of Gerês Propolis Collected in Different Years. | Plants (Basel) | 2023 | https://conductscience.org/library/papers/38005805 | PubMed |
| 37909529 | Effects of systemic Anatolian propolis administration on a rat-irradiated osteoradionecrosis model. | J Appl Oral Sci | 2023 | https://conductscience.org/library/papers/37909529 | PubMed |
| 37367153 | Evaluation of Propolis Hydrogel for the Treatment of Dentinal Sensitivity: A Clinical Study. | Gels | 2023 | https://conductscience.org/library/papers/37367153 | PubMed |
| 35702280 | Effects of propolis supplementation on irritable bowel syndrome with constipation (IBS-C) and mixed (IBS-M) stool pattern: A randomized, double-blind clinical trial. | Food Sci Nutr | 2022 | https://conductscience.org/library/papers/35702280 | PubMed |
| 35028635 | Propolis particles incorporated in aqueous formulations with enhanced antibacterial performance. | Food Hydrocoll Health | 2021 | https://conductscience.org/library/papers/35028635 | PubMed |
| 34443664 | Fatty Acid Analysis, Chemical Constituents, Biological Activity and Pesticide Residues Screening in Jordanian Propolis. | Molecules | 2021 | https://conductscience.org/library/papers/34443664 | PubMed |
| 34070497 | Application of Propolis in Protecting Skeletal and Periodontal Health-A Systematic Review. | Molecules | 2021 | https://conductscience.org/library/papers/34070497 | PubMed |
| 33406745 | The Cardiovascular Therapeutic Potential of Propolis-A Comprehensive Review. | Biology (Basel) | 2021 | https://conductscience.org/library/papers/33406745 | PubMed |
| 32890967 | Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19. | Biomed Pharmacother | 2020 | https://conductscience.org/library/papers/32890967 | PubMed |
| 32288745 | [Propolis: origin, composition and properties]. | Phytotherapie (Paris) | 2012 | https://conductscience.org/library/papers/32288745 | PubMed |
| 31762646 | Composition and functional properties of propolis (bee glue): A review. | Saudi J Biol Sci | 2019 | https://conductscience.org/library/papers/31762646 | PubMed |
| 31248192 | Use of nPSi-βCD Composite Microparticles for the Controlled Release of Caffeic Acid and Pinocembrin, Two Main Polyphenolic Compounds Found in a Chilean Propolis. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/31248192 | PubMed |
| 31075821 | Identification and Determination of Seven Phenolic Acids in Brazilian Green Propolis by UPLC-ESI-QTOF-MS and HPLC. | Molecules | 2019 | https://conductscience.org/library/papers/31075821 | PubMed |
| 31058881 | The Anti-Staphylococcal Potential of Ethanolic Polish Propolis Extracts. | Molecules | 2019 | https://conductscience.org/library/papers/31058881 | PubMed |
| 29921833 | Antifungal Activity and Synergism with Azoles of Polish Propolis. | Pathogens | 2018 | https://conductscience.org/library/papers/29921833 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1753797
GET https://conductscience.org/api/papers/v1/1753797/cited_by?page=2